Back to Woodline Partners LP Woodline Partners LP

ALGSALGS
8 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in ALIGOS THERAPEUTICS INC

Woodline Partners LP holds 177,362 shares of ALGS (ALIGOS THERAPEUTICS INC), worth $1M as of 2026-Q2. ALGS represents 0.0% of Woodline Partners LP's portfolio.

Current Value

$1M

Current Shares

177,362

Total Value Change

+$226,910

Total Shares Change

+85,391

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
177,362
0.0%
$1M0.0%$5.77
0
2026-Q1
Decreased
177,362
-38.7%
$1.3M0.0%$6.85
0
2025-Q4
Decreased
289,169
-38.2%
$2.7M0.0%$9.12
0
2025-Q3
Decreased
468,199
-9.7%
$4.6M0.0%$9.62
0
2025-Q2
Increased
518,300
+64.3%
$3.7M0.0%$7.21
39
2025-Q1
New
315,383
-
$2.6M0.0%$9.12
36
2024-Q4
Exited
0
-100.0%
$00.0%$40.47
0
2024-Q3
New
91,971
-
$796,4690.0%$8.04
34

Other major holders of ALGS: ADAGE CAPITAL PARTNERS GP, L.L.C., Alyeska Investment Group, L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used